The most popular Heart Sisters article in 2024
Heart Sisters
DECEMBER 29, 2024
Was this particular article the most popular of 2024 because my HEART SISTERS readers aren't getting clear jargon-free, patient-friendly answers from their doctors?
Article Related Topics 
Invited Article: Al guided Dual Antiplatelet Therapy and Anticoagulation
Journal of Cardiovascular Pharmacology
MAY 5, 2025
Artificial intelligence (AI) has emerged as a transformative tool in healthcare through data analysis, pattern recognition and predictive modeling capabilities. AI-driven approaches have the potential to positively transform patient care through personalized treatment regimens comprising antiplatelet and anticoagulant therapy.
Article 
73
73 
Call for a consensual definition of dyslipidemia in coronary angiography trials
Frontiers in Cardiovascular Medicine
FEBRUARY 4, 2025
We listed definitions and their references in the 258 articles the research found. Out of the 258 articles retrieved in the search, 52 studies (20%) provided a definition of dyslipidemia, and 20 (8%) mentioned the source. A systematic search of coronary angiography studies focusing on dyslipidemia was conducted.
Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients
Frontiers in Cardiovascular Medicine
APRIL 1, 2025
From a total of 452 records, 29 articles were eligible for full-text review, whereof, data from 14 articles were systematically collated.
Biomarkers 69
69 Letter by Pan et al Regarding Article, “Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment–Elevation Myocardial Infarction: An Individual Patient Meta-Analysis”
Circulation
JUNE 8, 2025
Circulation, Volume 151, Issue 23 , Page e1047-e1048, June 10, 2025.
Letter by Zhang and Zhong Regarding Article, “Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis”
Circulation
JUNE 15, 2025
Circulation, Volume 151, Issue 24 , Page e1072-e1072, June 17, 2025.
Article 45
45 
Deadline Extended: Special Collection on Artificial Intelligence in Cardiovascular Health
International Journal of Cardiovascular Sciences
DECEMBER 3, 2024
We would like to inform you that the deadline for submitting articles for the special collection on Artificial Intelligence in Cardiovascular Health has been extended to March 1, 2024. We look forward to your contribution to enrich this special edition!
Article 52
52 
Gene-related metabolic dysfunction may be driving heart arrhythmia
Science Daily - Heart Disease
AUGUST 12, 2024
Patients with a common heart arrhythmia called Atrial Fibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, according to a new article.
Arrhythmia 130
130 
Letter by de Tarso Müller Regarding Article, “Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing Subanalysis”
Circulation: Heart Failure
JUNE 18, 2025
Circulation: Heart Failure, Ahead of Print.
Exercise 40
40 
Letter by Murai et al Regarding Article, “Impact of Post-PCI Lipid Core Burden Index on Angiographic and Clinical Outcomes: Insights From NIRS-IVUS”
Circulation: Cardiovascular Imaging
JUNE 10, 2025
Circulation: Cardiovascular Imaging, Ahead of Print.
Response by Campo and Pavasini to Letter Regarding Article, “Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment–Elevation Myocardial Infarction: An Individual Patient Meta-Analysis”
Circulation
JUNE 8, 2025
Circulation, Volume 151, Issue 23 , Page e1049-e1050, June 10, 2025.
Response by Manuel to Letter Regarding Article, “Progressive LV Dysfunction and Adverse Outcomes After Aortic Valve Replacement With Bioprosthetic Valves in Young Patients”
Circulation: Cardiovascular Imaging
JUNE 11, 2025
Circulation: Cardiovascular Imaging, Ahead of Print.
Aortic valve 40
40 
Deadline Extended for Submissions to the AI in Cardiovascular Health Collection!
International Journal of Cardiovascular Sciences
MARCH 27, 2025
The International Journal of Cardiovascular Sciences has extended the deadline for article submissions to the special issue on Artificial Intelligence in Cardiovascular Health until August 30, 2025 ! Publications in this collection will continue until December 2025. More information: revistaijcs@cardiol.br
Article 52
52 
Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets
Frontiers in Cardiovascular Medicine
NOVEMBER 26, 2024
In light of the swift advancements in this domain, this review article is dedicated to examining lactylation in cardiovascular disease and potential drug targets for regulating lactylation, with the aim of enhancing comprehension of this intricate field.
'Paving the way' for improved treatment of premature aging disease
Science Daily - Heart Disease
OCTOBER 18, 2024
A new article could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes accelerated aging in children.
Article 119
119 Article 119
119 
MicroRNAs as regulators of cardiac dysfunction in sepsis: pathogenesis and diagnostic potential
Frontiers in Cardiovascular Medicine
FEBRUARY 17, 2025
Duplicate articles, those without abstracts or full texts, and review/meta-analyses or non-English articles were excluded. After initial filtering by the database search engine, Excel software was used to further screen references. miRNAs play diverse roles in SIMD.
Article 52
52 
Response by Vukadinović et al to Letter Regarding Article, “Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis”
Circulation
JUNE 15, 2025
Circulation, Volume 151, Issue 24 , Page e1073-e1074, June 17, 2025.
Article 45
45 
Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation
Frontiers in Cardiovascular Medicine
MARCH 25, 2025
This review article explores the intricate mechanisms by which uremic toxins accelerate vascular inflammation. These toxins play a pivotal role in mediating vascular inflammation, a key contributor to the high cardiovascular morbidity and mortality observed in CKD patients.
Dr. Rohan Khera and Dr. C. Michael Gibson discuss: Artificial Intelligence in cardiovascular care
Clinical Trial Results
JUNE 19, 2025
Michael Gibson discuss: Artificial Intelligence in cardiovascular care Search for: Search Search archived content (2018 and prior) Search June 19, 2025 Uncategorized Disclosures: Sponsored by BridgeBio Pharma, Inc Article Navigation Dr. Daniel Judge and Dr. C.
Article 61
61 Article 61
61 
'A hearty debate' concludes plant-based meat alternatives are healthier for your heart than meat
Science Daily - Heart Disease
JUNE 25, 2024
A review article of the available studies directly comparing the impact of plant-based and animal-based meats consistently suggests that the plant-based alternatives improve cardiovascular risk factors.
Article 120
120 
Response by Maurizi et al to Letter Regarding Article, “Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry”
Circulation
JUNE 1, 2025
Circulation, Volume 151, Issue 22 , Page e1045-e1046, June 3, 2025.
Article 45
45 
Letter by Rich-Edwards et al Regarding Article, “Assessing the Accuracy of Cardiovascular Disease Prediction Using Female-Specific Risk Factors in Women Aged 45 to 69 Years in the UK Biobank Study”
Circulation: Cardiovascular Quality & Outcomes
JUNE 16, 2025
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.
Risk Factors 40
40 
Enhancing microcirculation in STEMI patients: can intracoronary thrombolysis combined with thrombus aspiration provide an optimal strategy?
Frontiers in Cardiovascular Medicine
MARCH 28, 2025
This article explores the potential role of intracoronary thrombolysis, in conjunction with thrombus aspiration, in improving microcirculatory perfusion during PCI for STEMI patients. The current standard of care is primary percutaneous coronary intervention (PPCI), which aims to rapidly restore epicardial blood flow.
Thrombolysis 52
52 
Response by Doust et al to Letter Regarding Article “Assessing the Accuracy of Cardiovascular Disease Prediction Using Female-Specific Risk Factors in Women Aged 45 to 69 in the UK Biobank Study”
Circulation: Cardiovascular Quality & Outcomes
JUNE 16, 2025
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.
Risk Factors 40
40 
Artificial intelligence-generated podcasts open new doors to make science accessible: a mixed-method evaluation of quality and the potential for science communication
European Journal of Cardiovascular Nursing
JUNE 13, 2025
Methods and results We conducted a mixed-method evaluation of 10 AI-generated podcasts for articles published in the European Journal of Cardiovascular Nursing. Rigorous evaluation and transparency about the AI-generated nature of the podcast, referencing the original article and author acknowledgement were recommended.
Article 40
40 Cardiac defibrillation in humans
HeartRhythm
FEBRUARY 27, 2025
Because neither is alive to tell their story, I was asked to write the article, adding information on the early days of the implantable transvenous cardioverter. This article highlights the first attempts at ventricular defibrillation and the development of the implantable defibrillator and the implantable transvenous cardioverter.
Atrial fibrillation: A review
Science Daily - Heart Disease
DECEMBER 16, 2024
In a new review article scientists summarize the current evidence regarding the epidemiology, pathophysiology, diagnosis and management of AF. Significant complications associated with this condition include ischemic stroke, heart failure, myocardial infarction, chronic kidney disease, dementia and mortality.
Dr. Ron Witteles and Dr. C. Michael Gibson discuss: Atrial fibrillation, arrythmias, and other cardiac manifestations in patients with ATTR-CM
Clinical Trial Results
JUNE 9, 2025
Article Navigation Dr. Richard Cheng and Dr. C. Michael Gibson discuss: Atrial fibrillation, arrythmias, and other cardiac manifestations in patients with ATTR-CM Search for: Search Search archived content (2018 and prior) Search June 9, 2025 Uncategorized Disclosures: Sponsored by BridgeBio Pharma, Inc.
Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review
Heart BMJ
FEBRUARY 26, 2025
The purpose of this review article is to provide a summary of the current data regarding the functional assessment of CAD in patients with severe AS and highlight the current best practice in this evolving area.
Dual-task training and cognitive performance in individuals with coronary artery disease and/or heart failure: a systematic review
Frontiers in Cardiovascular Medicine
MARCH 5, 2025
The certainty of evidence was assessed using Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.ResultsA total of 2,098 articles were retrieved, and 21 articles were selected for full reading.
An approach to fluoroless radiofrequency atrial fibrillation ablation
Frontiers in Cardiovascular Medicine
JANUARY 21, 2025
In this article, we present our approach to fluoroless radiofrequency PVI using ICE and 3D electro-anatomical mapping. Additional advantages include providing electrophysiology lab personnel with a lead-free working environment and avoiding radiation exposure for both patients and physicians.
Dr. Daniel Judge and Dr. C. Michael Gibson discuss data presented at ACC 2025: Primary Endpoint Efficacy Results in The Attribute-CM Study: Pre-Specified Sensitivity Analyses Addressed Tafamidis Use. Sponsored by BridgeBio Pharma, Inc
Clinical Trial Results
JUNE 16, 2025
Article Navigation Dr. Nitasha Sarswat and Dr. C. Sponsored by BridgeBio Pharma, Inc Search for: Search Search archived content (2018 and prior) Search June 16, 2025 Uncategorized Disclosures: Sponsored by BridgeBio Pharma, Inc.
Article 52
52 
Motivational interviewing intervention for the management of hypertension: a meta-analysis
Frontiers in Cardiovascular Medicine
JANUARY 19, 2025
The search was restricted to articles published in English and Chinese languages. software was used for meta-analysis.ResultsA total of 16 RCTs were included. The meta-analysis findings demonstrate that motivational interviewing could reduce both systolic pressure [MD=3.26, 95% CI (5.16, 1.36), P 0.05).ConclusionsMotivational
Hypertension 52
52 
Dr. Brett Sperry and Dr. C. Michael Gibson discuss: Atrial fibrillation, arrythmias, and other cardiac manifestations in patients with ATTR-CM
Clinical Trial Results
JUNE 11, 2025
Article Navigation Dr. Ron Witteles and Dr. C. Michael Gibson discuss: Atrial fibrillation, arrythmias, and other cardiac manifestations in patients with ATTR-CM Search for: Search Search archived content (2018 and prior) Search June 11, 2025 Uncategorized Disclosures: Sponsored by BridgeBio Pharma, Inc.
Global scientific trends in hypercholesterolemia research from 2003 to 2023: a data-driven bibliometric and visual analysis
Frontiers in Cardiovascular Medicine
JUNE 10, 2025
published the highest number of related articles, whereas publications by Sabatine M.S. Among the researchers, Kastelein J.J.P. had the highest average citation.
Research 52
52 
Call for Assistant Editor
International Journal of Cardiovascular Sciences
APRIL 8, 2025
This is an excellent opportunity for early-career individuals in the cardiovascular health field who wish to develop editorial skills and contribute to the advancement of science in this area, as well as engage in the journals outreach activities.
Reassessing the role of tricuspid valve surgery in the modern era
Heart BMJ
MARCH 13, 2025
The article by Gwak et al provides a pivotal contribution to this field, illustrating that early surgical intervention for tricuspid regurgitation (TR) in patients with low to intermediate risk yields significant survival benefits.
Tricuspid 52
52 What Every Cardiologist Should Know About Contraception and Reproductive Planning in 2025
Journal of the American Heart Association
JUNE 11, 2025
The aim of this article is to review risks and advantages of available contraception and pregnancy termination options as it pertains to these high‐risk cardiac patients.
Nursing 40
40 
Dr. Nitasha Sarswat and Dr. C. Michael Gibson discuss datapresented at ACC 2025: Acoramidis-Mediated Early Increase in Serum Transthyretin Level Reduces Cardiovascular-Related Hospitalizations and Mortality: Insights From The Attribute-CM Study
Clinical Trial Results
JUNE 13, 2025
Michael Gibson discuss: Atrial fibrillation, arrythmias, and other cardiac manifestations in patients with ATTR-CM Footer Navigation LinkedIn Twitter Email Search for: Search Search archived content (2018 and prior) Search
Hospital 40
40 
Methods and validity indicators for measuring adherence and persistence to aspirin in secondary cardiovascular prevention: a systematic review
Frontiers in Cardiovascular Medicine
MAY 25, 2025
Two reviewers independently screened articles and extracted data on study characteristics, measurement methods, and validity indicators. The results were synthesized in tabular form according to method type (indirect or direct) and outcome assessed (adherence or persistence).
Article 52
52 
Ezetimibe Plus Statins Equals Better Outcomes
CardiacWire
MARCH 26, 2025
Digging through decades of data from PubMed, Embase, and ClinicalTrials.gov, researchers pooled all relevant articles published through June 2024 (108k patients) and found that a combination lipid-lowering therapy (LLT) of statins plus ezetimibe led to significantly better CV outcomes compared to statin monotherapy.
Outcomes 59
59 
Novel device therapies in heart failure: focus on patient selection
Frontiers in Cardiovascular Medicine
FEBRUARY 24, 2025
In light of these potential limitations, this review article proposes categorizing HF patients into four distinct phenoprofiles based on their tolerance to GDMT and candidacy for HRT. Considering these HF phenoprofiles may guide treatment decisions regarding the selection and use of novel device-based HF therapies.
The prevalence of dyslipidemia and its correlation with anti-retroviral therapy among people living with HIV in China: a systematic review and meta-analysis
Frontiers in Cardiovascular Medicine
JUNE 13, 2025
The study participants were divided into ART-naïve and ART-experienced PLWH. The prevalence of dyslipidemia and mean difference of serum lipids were estimated using random-effects models.
BMI 52
52 
Diagnostic accuracy of artificial intelligence models in detecting congenital heart disease in the second-trimester fetus through prenatal cardiac screening: a systematic review and meta-analysis
Frontiers in Cardiovascular Medicine
FEBRUARY 23, 2025
Articles were retrieved based on PRISMA Flow 2020 and inclusion and exclusion criteria. Artificial intelligence (AI)-powered ultrasound provides a potential solution to improve the diagnostic accuracy of fetal CHD screening.MethodsA literature search was conducted across seven databases for systematic review.
Let's personalize your content